Χώρα: Ελλάδα
Γλώσσα: Αγγλικά
Πηγή: HMA (Heads of Medicines Agencies)
progesterone 1.55 g
CEVA Santé Animale
QG03DA04
Vaginal device
progesterone
Cattle Females
2011-05-27
1/4 Dokument1 Aug. 07 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT PRID alpha 1.55 g vaginal delivery system for cattle [Austria, Belgium, Germany, Greece, Spain, Finland, Luxemburg, The Netherlands, Portugal] PRID 1.55 g vaginal delivery system for cattle [France] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Progesterone .............................................................................................. 1.55 g EXCIPIENTS: Excipients q.s..........................................................................................1 device For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Vaginal delivery system. A spiral device covered with an inert elastomer containing progesterone. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle: cows and heifers. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the control of the œstrus cycle in cows and heifers including: - Synchronisation of œstrus in cycling cattle. To be used in combination with a prostaglandin. - Induction and synchronisation of œstrus in non cycling cattle. To be used in combination with a prostaglandin (PGF2 ) and equine chorionic gonadotrophin (eCG, in the past called PMSG). 4.3 CONTRAINDICATIONS Do not use in pregnant cattle. Do not use in sexually immature heifers. Do not use before 35 days have passed since previous calving. Do not use in animals suffering from infectious or non-infectious disease of the genital tract. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES 2/4 Dokument1 Aug. 07 The progesterone treatment alone, Διαβάστε το πλήρες έγγραφο